How I treat elderly patients with NDMM

Multiple Myeloma Hub
28/05/2020 11 min
How I treat elderly patients with NDMM

Listen "How I treat elderly patients with NDMM "

Descargar episodio Ver en sitio original

Episode Synopsis

During COMy 2020, Paula Rodriguez Otero, Clínica Universidad de Navarra, Pamplona, ES, spoke to the Multiple Myeloma (MM) Hub. We asked: How should we treat elderly patients with newly diagnosed MM? A number of factors may influence a patient's eligibility for, and outcome to, different treatments in the MM setting. Here, Paula Rodriguez Otero discusses these factors and outlines the available treatment options for patients deemed ineligible for transplant. Hosted on Acast. See acast.com/privacy for more information.

More episodes of the podcast Multiple Myeloma Hub

Improving access to CAR T-cell therapy for eligible patients with MM 06/01/2026
ASH 2025 | CARTITUDE-4: Long-term PFS outcomes with cilta-cel for standard-risk RRMM 11/12/2025
Clinical experience with belantamab mafodotin: Management strategies for ocular toxicity 23/10/2025
MIDAS: MRD-driven strategy after Isa-KRd induction in ND ASCT-eligible MM 22/10/2025
How might the clinical development of CELMoDs impact the treatment paradigm for MM? 20/10/2025
CARTITUDE-2: Cilta-cel ± Len maintenance for MM with suboptimal response to ASCT 03/10/2025
Evolving diagnostic criteria for high-risk smoldering MM 30/09/2025
What combination regimens including BiTEs are being evaluated for the treatment of RRMM? 17/09/2025
Risk stratification and prognosis in smoldering MM 10/09/2025
What combination regimens containing BCMA-directed bispecific antibodies are being evaluated for MM? 09/09/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA